Raman spectroscopy is used to identify the biochemical differences between normal brain tissue (cerebellum and meninges) compared with tumor (glioblastoma, medulloblastoma, schwannoma and meningioma) through biochemical information obtained from the sample.
A total of 263 spectra were obtained from fragments of cerebellum normal (65), meninges normal (69), glioblastoma (28), schwannoma (8), medulloblastoma (19), and meningioma (74), which is collected using dispersive the Raman spectrometer ( 830 nm, near infrared power, output 350 mW, 20 s exposure time to obtain the spectrum), coupled to the Raman probe.
A model spectral based quadratic fit was developed to estimate the concentration of biochemistry of 16 biochemical compounds present in brain tissue, among them the most characterized the spectrum of brain tissue, such as linolenic acid, triolein, cholesterol, sphingomyelin, phosphatidylcholine, β-carotene, collagen, phenylalanine, DNA, glucose, and blood.
Of biochemical information, classification spectra in normal and tumor groups was performed according to the type of brain tumor and corresponding normal tissue. The classifications used in the model of discrimination is (a) the concentration of the biochemical constituents of the brain, through a linear discriminant analysis (LDA), and (b) the spectrum of the network, through discrimination by partial least squares (PLS-DA) regression.
The model obtained 93.3% accuracy with LDA discrimination between normal and tumor cerebellum groups separated according to the concentration of biochemical constituents and 94.1% in discrimination by PLS-DA using the whole spectrum. The results obtained showed that the Raman technique is a promising tool for distinguishing concentrations of biochemical compounds present in brain tissue, both normal and tumor. The concentration predicted by models of biochemical and all information contained in Raman spectra were both able to classify pathologic group.
Persistence biochemistry of prostate specific antigen after robot-assisted Laparoscopic Radical Prostatectomy: Tumor localization using PSMA PET / CT imaging
Since the introduction of radiolabeled prostate-specific membrane antigen (PSMA) positron emission tomography / computed tomography (PET / CT), the ability to visualize recurrent prostate cancer has increased substantially. However, PSMA radiolabeled diagnostic accuracy of PET / CT in patients with biochemical persistence (BCP; ie, continuously measured prostate-specific antigen (PSA) -values after robot-assisted laparoscopic radical prostatectomy (RARP)) largely lacking.
Therefore, the aim of this study was to determine the role of PSMA (ie, 18F-DCFPyL or 68Ga-PSMA-11) PET / CT imaging in patients with BCP after RARP and to evaluate the site of disease are persistent on PSMA PET / CT. Methods: A total of 150 consecutive patients with BCP after undergoing RARP PSMA radiolabeled PET / CT imaging were retrospectively evaluated. BCP is defined as any first detectable serum PSA values after RARP (≥0.1 ng / mL) for at least 6 weeks after surgery, the absence of an undetectable PSA values after RARP.
A multivariable logistic regression analysis was performed to identify predictors for the detection of metastases outside the prostate fossa (≥miN1) on PSMA PET / CT. Results: A PSMA PET / CT was performed in the PSA-median value of 0.60 ng / mL (interquartile range (IQR) from 0.3 to 2.4) after a median period of 6 months (IQR 4-10) following RARP. In total, 101/150 patients (67%) had lesions with PSMA-expression PET / CT, which was 89/150 patients (59%) had lesions with increased expression of PSMA sites outside the prostatic fossa.
Fermentation optimization, purification and biochemical characterization of ι-carrageenase of marine bacteria Cellulophaga Baltica
Degrading marine bacterium ι-carrageenan, Cellulophaga Baltica, isolated from the surface of red algae filaments fucoides Vertebrates. ι-carrageenase maximum production is optimized by single factor experiment. The optimum fermentation conditions was 1.6 g / L furcellaran, 4 g / L of yeast extract as a carbon source, 5 g / L sea salt, and 48 hours of incubation at 20 ° C. Extracellular ι-carrageenase of culture supernatant purified by ultrafiltration , ammonium sulfate precipitation, and finally with anion exchange chromatography, showing 26 fold increase in specific activity compared to that in the crude enzyme.
According to the results of SDS-PAGE and HPLC-SEC, estimated molecular weight of 31 kDa purified enzyme. Purified enzyme showed maximum specific activity of 571 U / mg at 40 ° C and pH 7.5 to 8.0. It retains 73% of the total activity below 40 ° C and 90% of total activity at pH 7.2.
Especially, the enzyme is ι-carrageenase cold-adapted, which showed 33.4% of the maximum activity at 10 ° C. The enzyme is stimulated by Na +, K +, and NH4 +, while Ca 2+, Mg 2+, Fe 3+, sea salt and EDTA acts as an inhibitor of the enzyme.
Effect of Ramadan intermittent fasting on cognitive responses, physical and biochemical for heavy short-term exercise in young female elite handball players
This study aims to assess the effects of intermittent fasting Ramadan (RF) in response to cognitive, physical and biochemistry to exercise in young female elite handball players. Twelve athletes participated in three experimental sessions: one week before Ramadan (BR), in the first week of Ramadan (FWR) and during the last week of Ramadan (LWR).
Crossover studies carried out in Tunisia during the 2013 Ramadan which takes place from 9 July to 7 August. During each session, a battery test is performed as follows: Index Hooper, tests alertness (VT), Epworth sleepiness scale (ESS), five test jump (5-JT), modified agility T-test (MAT), the maximum stood ball speed test – throw (MSBVT) and Running-based Anaerobic Sprint (RAST) test. Ratings of perceived exertion (RPE) was recorded immediately after the RAST.
Blood samples were taken before and after exercise during each session. The results showed that the higher the ESS score for LWR of BR (p <0.05). In addition, MSBVT time decreased (p <0.05) for LWR, because it improved performance. Strength three final sprint of RAST decreased significantly only for LWR compared with BR (p <0.05). RAST fatigue index and higher RPE scores for LWR more than BR (p <0.05).
The results showed also measures hematology (blood cell, namely, red, hemoglobin, and hematocrit), plasma osmolarity and energetic markers are not affected by RF. Biomarkers higher muscle damage after RAST only for LWR compared with BR (p <0.01 for all). In conclusion, increased RF performance decline RAST ESS and associated with higher muscle damage and fatigue, especially on the LWR. This change can be attributed to the previous and circadian rhythm sleep disorders than malnutrition or dehydratation.
GZMB Antibody |
|||
1-CSB-PA986806 | Cusabio |
|
|
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
anti- GZMB antibody |
|||
FNab03737 | FN Test | 100µg | EUR 702 |
Description: Antibody raised against GZMB |
GZMB / GZMH Antibody |
|||
20-abx329145 | Abbexa |
|
|
GZMB/GZMH Antibody |
|||
1-CSB-PA009072 | Cusabio |
|
|
Description: A polyclonal antibody against GZMB/GZMH. Recognizes GZMB/GZMH from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000 |
Granzyme B (GZMB) Antibody |
|||
abx233737-100ug | Abbexa | 100 ug | EUR 661.2 |
Granzyme B (GZMB) Antibody |
|||
20-abx225208 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx109837 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx176702 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx176703 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx172667 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx172668 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx210520 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx210840 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
abx139484-01mg | Abbexa | 0.1 mg | EUR 493.2 |
Granzyme B (GZMB) Antibody |
|||
abx332436-100ul | Abbexa | 100 ul | EUR 510 |
Granzyme B (GZMB) Antibody |
|||
20-abx112844 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx100561 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx128920 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx001994 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx013099 | Abbexa |
|
|
GZMB Antibody / Granzyme B |
|||
F54859-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response. |
GZMB Antibody / Granzyme B |
|||
F54859-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response. |
GZMB Antibody, HRP conjugated |
|||
1-CSB-PA010082LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
GZMB Antibody, FITC conjugated |
|||
1-CSB-PA010082LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
GZMB Antibody, Biotin conjugated |
|||
1-CSB-PA010082LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
GZMB Conjugated Antibody |
|||
C32711 | SAB | 100ul | EUR 476.4 |
GZMB Polyclonal Antibody |
|||
A71559 | EpiGentek |
|
|
GZMB Polyclonal Antibody |
|||
A55359 | EpiGentek |
|
|
Granzyme B (GZMB) Antibody (PE) |
|||
abx201109-100tests | Abbexa | 100 tests | EUR 710.4 |
Granzyme B (GZMB) Antibody (HRP) |
|||
20-abx108314 | Abbexa |
|
|
Granzyme B (GZMB) Antibody (FITC) |
|||
20-abx106894 | Abbexa |
|
|
Anti-Granzyme B/Gzmb Antibody |
|||
A00353-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-Granzyme B/GZMB Antibody |
|||
PA1738 | BosterBio | 100ug/vial | EUR 352.8 |
Human Granzyme B (GZMB) Antibody |
|||
32100-05111 | AssayPro | 150 ug | EUR 313.2 |
Granzyme B (GZMB) Antibody (Biotin) |
|||
20-abx105476 | Abbexa |
|
|
Granzyme B (GZMB) Antibody (Biotin) |
|||
abx413730-01mg | Abbexa | 0.1 mg | EUR 710.4 |
Human Granzyme B (GZMB) Antibody (Biotin Conjugate) |
|||
32100-05121 | AssayPro | 150 ug | EUR 442.8 |
GZMB Polyclonal Antibody, HRP Conjugated |
|||
A55360 | EpiGentek |
|
|
GZMB Polyclonal Antibody, FITC Conjugated |
|||
A55361 | EpiGentek |
|
|
GZMB Polyclonal Antibody, Biotin Conjugated |
|||
A55362 | EpiGentek |
|
|
Gzmb/ Rat Gzmb ELISA Kit |
|||
ELI-02162r | Lifescience Market | 96 Tests | EUR 1063.2 |
Granzyme B (GZMB) Polyclonal Antibody (Mouse) |
|||
4-PAA600Mu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Granzyme B (GZMB) |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC942403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF594 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC942403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF594 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC802403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC802403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC702403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF770 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC702403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF770 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC882403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF488A conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC882403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF488A conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC812403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC812403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC402403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF640R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC402403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF640R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC052403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405M conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC052403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405M conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC042403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405S conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC042403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405S conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCAP2403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCAP2403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCA2403-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), APC conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCP2403-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), PerCP conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCR2403-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), RPE conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCH2403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCH2403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCB2403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Biotin conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNCB2403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Biotin conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNUB2403-100 | Biotium | 100uL | EUR 316.8 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Concentration: 0.2mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNUB2403-50 | Biotium | 50uL | EUR 486 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), 1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNUB2403-500 | Biotium | 500uL | EUR 615.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Concentration: 0.2mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC472403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF647 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC472403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF647 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC552403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF555 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC552403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF555 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC612403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF660R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC612403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF660R conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC432403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF543 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC432403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF543 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC682403-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF568 conjugate, Concentration: 0.1mg/mL |
Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody |
|||
BNC682403-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF568 conjugate, Concentration: 0.1mg/mL |
Granzyme B (GZMB) Polyclonal Antibody (Mouse), PE |
|||
4-PAA600Mu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Granzyme B (GZMB). This antibody is labeled with PE. |
Polyclonal GZMB / Granzyme B Antibody (aa10-59) |
|||
APR02925G | Leading Biology | 0.05ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GZMB / Granzyme B (aa10-59). This antibody is tested and proven to work in the following applications: |
Granzyme B (GZMB) Polyclonal Antibody (Mouse), APC |
|||
4-PAA600Mu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Granzyme B (GZMB). This antibody is labeled with APC. |
Granzyme B (GZMB) Polyclonal Antibody (Mouse), Cy3 |
|||
4-PAA600Mu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Granzyme B (GZMB). This antibody is labeled with Cy3. |
Granzyme B (GZMB) Polyclonal Antibody (Mouse), HRP |
|||
4-PAA600Mu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Granzyme B (GZMB). This antibody is labeled with HRP. |
Granzyme B (GZMB) Polyclonal Antibody (Mouse), FITC |
|||
4-PAA600Mu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Granzyme B (GZMB). This antibody is labeled with FITC. |
Granzyme B (GZMB) Polyclonal Antibody (Human, Mouse) |
|||
4-PAA600Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Granzyme B (GZMB) |
Polyclonal GZMB / Granzyme B Antibody (N-Terminus) |
|||
APR02530G | Leading Biology | 0.05ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GZMB / Granzyme B (N-Terminus). This antibody is tested and proven to work in the following applications: |
Granzyme B (GZMB) Polyclonal Antibody (Mouse), Biotinylated |
|||
4-PAA600Mu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Granzyme B (GZMB). This antibody is labeled with Biotin. |
Granzyme B (GZMB) Polyclonal Antibody (Human, Mouse), PE |
|||
4-PAA600Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Granzyme B (GZMB). This antibody is labeled with PE. |
Granzyme B (GZMB) Polyclonal Antibody (Human, Mouse), APC |
|||
4-PAA600Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Granzyme B (GZMB). This antibody is labeled with APC. |
Granzyme B (GZMB) Polyclonal Antibody (Human, Mouse), Cy3 |
|||
4-PAA600Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Granzyme B (GZMB). This antibody is labeled with Cy3. |
Granzyme B (GZMB) Polyclonal Antibody (Human, Mouse), HRP |
|||
4-PAA600Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Granzyme B (GZMB). This antibody is labeled with HRP. |
Granzyme B (GZMB) Polyclonal Antibody (Mouse), APC-Cy7 |
|||
4-PAA600Mu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Mouse Granzyme B (GZMB). This antibody is labeled with APC-Cy7. |
GZMB siRNA |
|||
20-abx918984 | Abbexa |
|
|
GZMB siRNA |
|||
20-abx918985 | Abbexa |
|
|
GZMB siRNA |
|||
20-abx902389 | Abbexa |
|
|
Granzyme B (GZMB) Polyclonal Antibody (Human, Mouse), FITC |
|||
4-PAA600Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Granzyme B (GZMB). This antibody is labeled with FITC. |
Human Granzyme B (GZMB) AssayLite Antibody (RPE Conjugate) |
|||
32100-05151 | AssayPro | 150 ug | EUR 513.6 |
Human Granzyme B (GZMB) AssayLite Antibody (APC Conjugate) |
|||
32100-05161 | AssayPro | 150 ug | EUR 513.6 |
Human Granzyme B (GZMB) AssayLite Antibody (FITC Conjugate) |
|||
32100-05141 | AssayPro | 150 ug | EUR 513.6 |
Human Granzyme B (GZMB) AssayLite Antibody (PerCP Conjugate) |
|||
32100-05171 | AssayPro | 150 ug | EUR 565.2 |
Granzyme B (GZMB) Polyclonal Antibody (Human, Mouse), Biotinylated |
|||
4-PAA600Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Granzyme B (GZMB). This antibody is labeled with Biotin. |
Granzyme B (GZMB) Polyclonal Antibody (Human, Mouse), APC-Cy7 |
|||
4-PAA600Hu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Granzyme B (GZMB). This antibody is labeled with APC-Cy7. |
GZMB Rabbit pAb |
|||
A2557-100ul | Abclonal | 100 ul | EUR 369.6 |
GZMB Rabbit pAb |
|||
A2557-200ul | Abclonal | 200 ul | EUR 550.8 |
GZMB Rabbit pAb |
|||
A2557-20ul | Abclonal | 20 ul | EUR 219.6 |
GZMB Rabbit pAb |
|||
A2557-50ul | Abclonal | 50 ul | EUR 267.6 |
GZMB cloning plasmid |
|||
CSB-CL010082HU-10ug | Cusabio | 10ug | EUR 279.6 |
Description: A cloning plasmid for the GZMB gene. |
GZMB Blocking Peptide |
|||
DF7012-BP | Affbiotech | 1mg | EUR 234 |
Human Granzyme B (GZMB) AssayLite Antibody (FITC, RPE, APC, PerCP Conjugate) |
|||
32100-05181 | AssayPro | 1 x 75 ug, 3 x 30 ug | EUR 702 |
GZMB protein (His tag) |
|||
80R-4112 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Recombinant Human GZMB protein (His tag) |
Human GZMB ELISA Kit |
|||
ELA-E0600h | Lifescience Market | 96 Tests | EUR 988.8 |
GzmB ELISA KIT|Human |
|||
EF003968 | Lifescience Market | 96 Tests | EUR 826.8 |
Rat GZMB shRNA Plasmid |
|||
20-abx987795 | Abbexa |
|
|
Human Granzyme B (GZMB) |
|||
1-CSB-YP010082HU | Cusabio |
|
|
Description: Recombinant Human Granzyme B(GZMB) expressed in Yeast |
Human Granzyme B (GZMB) |
|||
1-CSB-EP010082HU | Cusabio |
|
|
Description: Recombinant Human Granzyme B(GZMB) expressed in E.coli |
Human GZMB shRNA Plasmid |
|||
20-abx952037 | Abbexa |
|
|
Mouse GZMB shRNA Plasmid |
|||
20-abx970718 | Abbexa |
|
|
GZMB Recombinant Protein (Rat) |
|||
RP204089 | ABM | 100 ug | Ask for price |
Recombinant Granzyme B (GZMB) |
|||
4-RPA600Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Granzyme B expressed in: E.coli |
Recombinant Granzyme B (GZMB) |
|||
4-RPA600Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Granzyme B expressed in: E.coli |
GZMB Recombinant Protein (Human) |
|||
RP014305 | ABM | 100 ug | Ask for price |
GZMB Recombinant Protein (Mouse) |
|||
RP140612 | ABM | 100 ug | Ask for price |
Gzmb ORF Vector (Rat) (pORF) |
|||
ORF068031 | ABM | 1.0 ug DNA | EUR 607.2 |
GZMB ORF Vector (Human) (pORF) |
|||
ORF004769 | ABM | 1.0 ug DNA | EUR 114 |
Gzmb ORF Vector (Mouse) (pORF) |
|||
ORF046872 | ABM | 1.0 ug DNA | EUR 607.2 |
Rat Granzyme B (GZMB) Protein |
|||
20-abx653633 | Abbexa |
|
|
GZMB ELISA Kit (Rat) (OKEH03163) |
|||
OKEH03163 | Aviva Systems Biology | 96 Wells | EUR 794.4 |
Description: Description of target: This enzyme is necessary for target cell lysis in cell-mediated immune responses. It cleaves after Asp. Seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution. Cleaves caspase-3, -7, -9 and 10 to give rise to active enzymes mediating apoptosis.;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 7.86 pg/mL |
GZMB ELISA Kit (Rat) (OKCD06565) |
|||
OKCD06565 | Aviva Systems Biology | 96 Wells | EUR 981.6 |
Description: Description of target: This enzyme is necessary for target cell lysis in cell-mediated immune responses. It cleaves after Asp. Seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution. Cleaves caspase-3, -7, -9 and 10 to give rise to active enzymes mediating apoptosis.;Species reactivity: Rat;Application: ELISA;Assay info: ;Sensitivity: < 6.3pg/mL |
Mouse Granzyme B (GZMB) Protein |
|||
20-abx066910 | Abbexa |
|
|
Human Granzyme B (GZMB) Protein |
|||
20-abx166567 | Abbexa |
|
|
GZMB ELISA Kit (Mouse) (OKBB00899) |
|||
OKBB00899 | Aviva Systems Biology | 96 Wells | EUR 606 |
Description: Description of target: Granzyme B is a serine protease that in humans is encoded by the GZMB gene. Granzyme B is expressed by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. CTL and NK cells share the remarkable ability to recognize specific infected target cells. They are thought to protect their host by inducing apoptosis of cells that bear on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
GZMB ELISA Kit (Human) (OKAN04370) |
|||
OKAN04370 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
Description: Description of target: This gene encodes a member of the granzyme subfamily of proteins, part of the peptidase S1 family of serine proteases. The encoded preproprotein is secreted by natural killer (NK) cells and cytotoxic T lymphocytes (CTLs) and proteolytically processed to generate the active protease, which induces target cell apoptosis. This protein also processes cytokines and degrades extracellular matrix proteins, and these roles are implicated in chronic inflammation and wound healing. Expression of this gene may be elevated in human patients with cardiac fibrosis.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 30 pg/mL |
GZMB ELISA Kit (Mouse) (OKEH04356) |
|||
OKEH04356 | Aviva Systems Biology | 96 Wells | EUR 794.4 |
Description: Description of target: This gene encodes a member of the granzyme subfamily of proteins, part of the peptidase S1 family of serine proteases. The encoded preproprotein is secreted by natural killer (NK) cells and cytotoxic T lymphocytes (CTLs) and proteolytically processed to generate the active protease, which induces target cell apoptosis. This protein also processes cytokines and degrades extracellular matrix proteins, and these roles are implicated in chronic inflammation and wound healing. Mice lacking a functional copy of this gene exhibit impaired immune cell-mediated cytolysis. ;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 7.84 pg/mL |
GZMB ELISA Kit (Human) (OKCD06563) |
|||
OKCD06563 | Aviva Systems Biology | 96 Wells | EUR 794.4 |
Description: Description of target: This gene encodes a member of the granzyme subfamily of proteins, part of the peptidase S1 family of serine proteases. The encoded preproprotein is secreted by natural killer (NK) cells and cytotoxic T lymphocytes (CTLs) and proteolytically processed to generate the active protease, which induces target cell apoptosis. This protein also processes cytokines and degrades extracellular matrix proteins, and these roles are implicated in chronic inflammation and wound healing. Expression of this gene may be elevated in human patients with cardiac fibrosis.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 2.7pg/mL |
GZMB ELISA Kit (Mouse) (OKCD06564) |
|||
OKCD06564 | Aviva Systems Biology | 96 Wells | EUR 934.8 |
Description: Description of target: This gene encodes a member of the granzyme subfamily of proteins, part of the peptidase S1 family of serine proteases. The encoded preproprotein is secreted by natural killer (NK) cells and cytotoxic T lymphocytes (CTLs) and proteolytically processed to generate the active protease, which induces target cell apoptosis. This protein also processes cytokines and degrades extracellular matrix proteins, and these roles are implicated in chronic inflammation and wound healing. Mice lacking a functional copy of this gene exhibit impaired immune cell-mediated cytolysis.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 6.4pg/mL |
Rat Granzyme B (GZMB) CLIA Kit |
|||
20-abx491739 | Abbexa |
|
|
Rat Granzyme B (GZMB) ELISA Kit |
|||
abx256311-96tests | Abbexa | 96 tests | EUR 848.4 |
Rat Granzyme B (GZMB) ELISA Kit |
|||
20-abx155605 | Abbexa |
|
|
Pig Granzyme B (GZMB) ELISA Kit |
|||
abx361654-96tests | Abbexa | 96 tests | EUR 990 |
Rat Granzyme B (GZMB) ELISA Kit |
|||
DLR-GZMB-Ra-48T | DL Develop | 48T | EUR 609.6 |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Granzyme B (GZMB) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat Granzyme B (GZMB) ELISA Kit |
|||
DLR-GZMB-Ra-96T | DL Develop | 96T | EUR 793.2 |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Granzyme B (GZMB) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat Gzmb(Granzyme B) ELISA Kit |
|||
ER0333 | FN Test | 96T | EUR 681.12 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 9.375pg/ml |